About PRIMO
About PRIMO
PRIMO stands for the “Practical Research for Innovative Cancer Control Management Office.” PRIMO’s mission is to assist the program supervisor (PS) and the program officers (POs) as they manage research progress, and to help promote the Practical Research for Innovative Cancer Control program.
Positioning of this website
This website is operated by the Practical Research for Innovative Cancer Control Management Office (PRIMO). It provides services for researchers who engage in the Practical Research for Innovative Cancer Control program, which is under the jurisdiction of the Division of Cancer Research in the Department of Research Promotion of the Japan Agency for Medical Research and Development (AMED). It also communicates notices and research results to the public.
Our relationship with the Japan Agency for Medical Research and Development (AMED)
The Japan Agency for Medical Research and Development (AMED) was established in April 2015. AMED pursues nine projects, five of which are “cross-section” projects and four of which are “disease-area specific” comprehensive projects. (There are
also other cross-section and disease-area specific projects.) The Japan Cancer Research Project (JCRP) is one of the disease-area specific projects.
The Practical Research for Innovative Cancer Control Management Office (PRIMO) is the support office for the Practical Research for Innovative Cancer Control of a part of JCRP that carries out research and development programs adopted
for the Practical Research for Innovative Cancer Control program, which is under the jurisdiction of the Division of Cancer Research in the Department of Research Promotion. Along these lines, PRIMO builds and operates organizations that provide
strategic support to the Practical Research for Innovative Cancer Control program.
For more about the Japan Agency for Medical Research and Development (AMED), please visit the website below:
https://www.amed.go.jp/
About the Japan Cancer Research Project (JCRP)
The Japan Cancer Research Project (JCRP) consists of the five programs listed below under “Japan Cancer Research Project.”
- Drug Discovery & Development
- Medical Device Development
- Translational & Clinical Research Core Centers
- Japan Regenerative Medicine Project
- Japan Genomic Medicine Program
- Japan Cancer Research Project
- Project for Cancer Research and Therapeutic Evolution (P-CREATE)
- Practical Research for Innovative Cancer Control
- Development of Medical Devices and Systems for Advanced Medical
- Program for an Integrated Database for Clinical and Genomic Information
- Project Focused on Developing Key Technology for Discovering and Manufacturing Drugs for Next-Generation Treatment and Diagnosis
- Psychiatric & Neurological Disorders
- Emerging/Re-Emerging Infectious Disease Project of Japan
- Rare/Intractable Disease Project of Japan
- R&D Project for Promotion of Health, Healthcare Strategy
https://www.amed.go.jp/program/list/index06.html
Overview of the Practical Research for Innovative Cancer Control program
The program for Practical Research for Innovative Cancer Control conducts studies in the following six domains. This website provides strategic support to over 200 research and development themes that fall under these six domains.
- Domain 1: Research on the true nature of cancer
- Domain 2: Research on cancer prevention and early detection methods
- Domain 3: Research on the development of new drugs that treat unmet medical needs
- Domain 4: Research on the development of new patient-friendly medical technologies
- Domain 5: Research on the creation of new treatment standards
- Domain 6: Focused research centered on life stages and the characteristics of cancer
The program director (PD), the program supervisor (PS), and the program officers (POs) for Practical Research for Innovative Cancer Control program are listed below.
| Program Director (PD) | Tomomitsu Hotta （National Cancer Center Japan / Nagoya Medical Center） |
|---|
| Program Supervisor (PS) | Tomomitsu Hotta （National Cancer Center Japan / Nagoya Medical Center） |
|---|
| Domain | PO（Program Officer） | Research Theme |
|---|---|---|
| Domain1 | Hitoshi Nakagama （National Cancer Center Japan） |
Research on the true nature of cancer |
| Yoshihiro Yoneda （National Institute of Biomedical Innovation, Health and Nutrition） |
||
| Domain2 | Tomotaka Sobue （Osaka University） |
Research on cancer prevention and early detection methods |
| Chisato Nagata （Gifu University） |
||
| Domain3 | Atsushi Otsu （National Cancer Center Hospital East） |
Research on the development of new drugs that treat unmet medical needs |
| Shin-ichi Nihira （The Tokyo Biochemical Research Foundation Comprehensive Academy for Advanced Oncology Unit） |
||
| Domain4 | Makoto Akabori （IBERICA Co., Ltd.） |
Research on the development of new patient-friendly medical technologies |
| Yoshikazu Kagami （Showa University） |
||
| Domain5 | Takeshi Sano （Cancer Institute Hospital of JFCR） |
Research on the creation of new treatment standards |
| Kazuo Tamura （Fukuoka University） |
||
| Domain6 | Keizo Horibe （Nagoya Medical Center） |
Focused research centered on life stages and the characteristics of cancer
(Research on childhood cancers, geriatric cancers, refractory cancers, and rare cancers)* *Including research on adolescent and young adult (AYA) cancers |
| Toshiaki Saeki （Saitama Medical University International Medical Center） |
Information for researchers; eligible for login access
The following information is available to the primary investigators of the research and development themes that have been adopted for the Practical Research for Innovative Cancer Control program.
- Login access is available only to the primary investigators of the adopted research and development themes
- The following services are provided to primary investigators who have logged in.
- The Research Progress Management System
- The AI-supported Researcher Mapping System
- Information on intellectual property consultation
- Information on research ethics consultation
Introducing the Practical Research for Innovative Cancer Control Management Office (PRIMO)
The Practical Research for Innovative Cancer Control Management Office (PRIMO) was established in January 2018 within the National Cancer Center Japan. The organization is not related to the Center’s other functions.
In November 2018, PRIMO
has ten members: an office head, five project managers, a system administrator, an administrative member, an intellectual property consultation member, and a research ethics consultation member.
PRIMO’s primary mission is as follows:
Mission : PRIMO’s mission is to assist the program supervisor (PS) and program officers (POs) as they manage research progress, and to help promote the Practical Research for Innovative Cancer Control program.
- In collaboration with the Japan Agency for Medical Research and Development (AMED), PRIMO manages the Research Progress Management System to support progress on research and development themes
- Using the Research Progress Management System, PRIMO collects and organizes information on the progress of each research and development theme, and creates and analyzes the materials necessary for meetings under the direction of the program supervisor and program officers
- Processes data on research articles with the use of artificial intelligence (AI) to develop and operate the AI-supported Researcher Mapping System to provide information to researchers
- Consults on intellectual property and research ethics
- Creates and manage portal sites
About the PRIMO logo
The logo is a stylized “P,” the first letter of “PRIMO.”
The hexagon represents the six domains of the Practical Research for Innovative Cancer Control program and the chemical structural formula. The pillar under the hexagon indicates that PRIMO supports research projects and symbolizes our eagerness to promote world-class cancer treatment through our sponsored research and development projects.